-
1
-
-
84988934951
-
-
NICE Guideline CG134 Published December 2011 accessed Apr
-
NICE Guideline CG134. Anaphylaxis: assessment and referral after emergency treatment. Published December 2011. https:// www.nice.org.uk/guidance/cg134/chapter/1-Recommendations (accessed Apr 2016)
-
(2016)
Anaphylaxis: Assessment and Referral after Emergency Treatment
-
-
-
3
-
-
84863741403
-
Tryptase in diagnosing adverse suspected anaphylactic reaction
-
Michalska-Krzanowska G. Tryptase in diagnosing adverse suspected anaphylactic reaction. Adv Clin Exp Med 2012;21:403-8
-
(2012)
Adv Clin Exp Med
, vol.21
, pp. 403-408
-
-
Michalska-Krzanowska, G.1
-
4
-
-
0024547878
-
Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis
-
Schwartz LB, Yunginger JW, Miller J, et al. Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis. J Clin Invest 1989;83:1551-5
-
(1989)
J Clin Invest
, vol.83
, pp. 1551-1555
-
-
Schwartz, L.B.1
Yunginger, J.W.2
Miller, J.3
-
5
-
-
84866713497
-
Usefulness and limitations of sequential serum tryptase for the diagnosis of anaphylaxis in 102 patients
-
Sala-Cunill A, Cardona V, Labrador-Horrillo M, et al. Usefulness and limitations of sequential serum tryptase for the diagnosis of anaphylaxis in 102 patients. Int Arch Allergy Immunol 2013;160:192-9
-
(2013)
Int Arch Allergy Immunol
, vol.160
, pp. 192-199
-
-
Sala-Cunill, A.1
Cardona, V.2
Labrador-Horrillo, M.3
-
6
-
-
0028232164
-
Development of a new, more sensitive immunoassay for human tryptase: Use in systemic-anaphylaxis
-
Schwartz LB, Bradford TR, Rouse C, et al. Development of a new, more sensitive immunoassay for human tryptase: use in systemic-anaphylaxis. J Clin Immunol 1994;14:190-204
-
(1994)
J Clin Immunol
, vol.14
, pp. 190-204
-
-
Schwartz, L.B.1
Bradford, T.R.2
Rouse, C.3
-
7
-
-
70449718862
-
Serum tryptase levels in atopic and nonatopic children
-
Komarow HD, Hu Z, Brittain E, et al. Serum tryptase levels in atopic and nonatopic children. J Allergy Clin Immunol 2009;124:845-8
-
(2009)
J Allergy Clin Immunol
, vol.124
, pp. 845-848
-
-
Komarow, H.D.1
Hu, Z.2
Brittain, E.3
-
9
-
-
70350525136
-
Determination of the baseline tryptase level in a pediatric population
-
Ibrahim Z, Bongrand P, Carayon P, et al. Determination of the baseline tryptase level in a pediatric population. Rev Fr D Allergol 2009;49:524-7
-
(2009)
Rev Fr D Allergol
, vol.49
, pp. 524-527
-
-
Ibrahim, Z.1
Bongrand, P.2
Carayon, P.3
-
10
-
-
84988962779
-
-
Phadia Product Information (accessed Apr 2016)
-
Phadia Product Information. http://www.phadia.com/en/ Products/Allergy-testing-products/ImmunoCAP-Lab-Tests/ ImmunoCAP-Tryptase/ (accessed Apr 2016)
-
-
-
-
11
-
-
84951854198
-
Tryptase levels in children presenting with anaphylaxis: Temporal trends and associated factors
-
De Schryver S, Halbrich M, Clarke A, et al. Tryptase levels in children presenting with anaphylaxis: temporal trends and associated factors. J Allergy Clin Immunol 2016;137:1138-42
-
(2016)
J Allergy Clin Immunol
, vol.137
, pp. 1138-1142
-
-
De Schryver, S.1
Halbrich, M.2
Clarke, A.3
-
12
-
-
84887025894
-
Anaphylaxis: Clinical patterns, mediator release, and severity
-
Brown SG, Stone SF, Fatovich DM, et al. Anaphylaxis: clinical patterns, mediator release, and severity. J Allergy Clin Immunol 2013;132:1141-49.e5
-
(2013)
J Allergy Clin Immunol
, vol.132
, pp. 1141e5-1149e5
-
-
Brown, S.G.1
Stone, S.F.2
Fatovich, D.M.3
-
14
-
-
80052334022
-
Usefulness of post mortem determination of serum tryptase, histamine and diamine oxidase in the diagnosis of fatal anaphylaxis
-
Mayer DE, Krauskopf A, Hemmer W, et al. Usefulness of post mortem determination of serum tryptase, histamine and diamine oxidase in the diagnosis of fatal anaphylaxis. Forensic Sci Int 2011;212:96-101
-
(2011)
Forensic Sci Int
, vol.212
, pp. 96-101
-
-
Mayer, D.E.1
Krauskopf, A.2
Hemmer, W.3
-
15
-
-
34249011852
-
Mast cell tryptase in postmortem serum-reference values and confounders
-
Edston E, Eriksson O, van Hage M. Mast cell tryptase in postmortem serum-reference values and confounders. Int J Legal Med 2007;121:275-80
-
(2007)
Int J Legal Med
, vol.121
, pp. 275-280
-
-
Edston, E.1
Eriksson, O.2
Van Hage, M.3
-
16
-
-
84893712099
-
Postmortem serum tryptase levels in anaphylactic and non-anaphylactic deaths
-
McLean-Tooke A, Goulding M, Bundell C, et al. Postmortem serum tryptase levels in anaphylactic and non-anaphylactic deaths. J Clin Pathol 2014;67:134-8
-
(2014)
J Clin Pathol
, vol.67
, pp. 134-138
-
-
McLean-Tooke, A.1
Goulding, M.2
Bundell, C.3
-
17
-
-
84873728658
-
Importance of serum basal tryptase levels in children with insect venom allergy
-
Yavuz ST, Sackesen C, Sahiner UM, et al. Importance of serum basal tryptase levels in children with insect venom allergy. Allergy 2013;68:386-91
-
(2013)
Allergy
, vol.68
, pp. 386-391
-
-
Yavuz, S.T.1
Sackesen, C.2
Sahiner, U.M.3
-
18
-
-
84893059575
-
Serum basal tryptase may be a good marker for predicting the risk of anaphylaxis in children with food allergy
-
Sahiner UM, Yavuz ST, Buyuktiryaki B, et al. Serum basal tryptase may be a good marker for predicting the risk of anaphylaxis in children with food allergy. Allergy 2014;69:265-8
-
(2014)
Allergy
, vol.69
, pp. 265-268
-
-
Sahiner, U.M.1
Yavuz, S.T.2
Buyuktiryaki, B.3
-
19
-
-
58149161786
-
Utility of the World Health Organization classification criteria for the diagnosis of systemic mastocytosis in bone marrow
-
Johnson MR, Verstovsek S, Jorgensen JL, et al. Utility of the World Health Organization classification criteria for the diagnosis of systemic mastocytosis in bone marrow. Mod Pathol 2009;22:50-7
-
(2009)
Mod Pathol
, vol.22
, pp. 50-57
-
-
Johnson, M.R.1
Verstovsek, S.2
Jorgensen, J.L.3
-
20
-
-
70349256069
-
Elevated tryptase levels selectively cluster in myeloid neoplasms: A novel diagnostic approach and screen marker in clinical haematology
-
Sperr WR, El-Samahi A, Kundi M, et al. Elevated tryptase levels selectively cluster in myeloid neoplasms: a novel diagnostic approach and screen marker in clinical haematology. Eur J Clin Invest 2009;39:914-23
-
(2009)
Eur J Clin Invest
, vol.39
, pp. 914-923
-
-
Sperr, W.R.1
El-Samahi, A.2
Kundi, M.3
|